These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Docking on Lipid II-A Widespread Mechanism for Potent Bactericidal Activities of Antibiotic Peptides. Grein F; Schneider T; Sahl HG J Mol Biol; 2019 Aug; 431(18):3520-3530. PubMed ID: 31100388 [TBL] [Abstract][Full Text] [Related]
7. Class A PBPs: It is time to rethink traditional paradigms. Straume D; Piechowiak KW; Kjos M; Håvarstein LS Mol Microbiol; 2021 Jul; 116(1):41-52. PubMed ID: 33709487 [TBL] [Abstract][Full Text] [Related]
8. In vitro reconstitution of peptidoglycan assembly from the Gram-positive pathogen Streptococcus pneumoniae. Zapun A; Philippe J; Abrahams KA; Signor L; Roper DI; Breukink E; Vernet T ACS Chem Biol; 2013 Dec; 8(12):2688-96. PubMed ID: 24044435 [TBL] [Abstract][Full Text] [Related]
9. An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Hasper HE; Kramer NE; Smith JL; Hillman JD; Zachariah C; Kuipers OP; de Kruijff B; Breukink E Science; 2006 Sep; 313(5793):1636-7. PubMed ID: 16973881 [TBL] [Abstract][Full Text] [Related]
11. An oldie but a goodie - cell wall biosynthesis as antibiotic target pathway. Schneider T; Sahl HG Int J Med Microbiol; 2010 Feb; 300(2-3):161-9. PubMed ID: 20005776 [TBL] [Abstract][Full Text] [Related]
12. Structural variations of the cell wall precursor lipid II in Gram-positive bacteria - Impact on binding and efficacy of antimicrobial peptides. Münch D; Sahl HG Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3062-71. PubMed ID: 25934055 [TBL] [Abstract][Full Text] [Related]
13. Class A PBPs have a distinct and unique role in the construction of the pneumococcal cell wall. Straume D; Piechowiak KW; Olsen S; Stamsås GA; Berg KH; Kjos M; Heggenhougen MV; Alcorlo M; Hermoso JA; Håvarstein LS Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6129-6138. PubMed ID: 32123104 [TBL] [Abstract][Full Text] [Related]
14. Microtiter plate bioassay to monitor the interference of antibiotics with the lipid II cycle essential for peptidoglycan biosynthesis. Burkard M; Stein T J Microbiol Methods; 2008 Sep; 75(1):70-4. PubMed ID: 18558445 [TBL] [Abstract][Full Text] [Related]
15. Lipid II as a target for antibiotics. Breukink E; de Kruijff B Nat Rev Drug Discov; 2006 Apr; 5(4):321-32. PubMed ID: 16531990 [TBL] [Abstract][Full Text] [Related]
16. Insight into Elongation Stages of Peptidoglycan Processing in Bacterial Cytoplasmic Membranes. Kim S; Pires MM; Im W Sci Rep; 2018 Dec; 8(1):17704. PubMed ID: 30531805 [TBL] [Abstract][Full Text] [Related]
17. Detection of lipid-linked peptidoglycan precursors by exploiting an unexpected transpeptidase reaction. Qiao Y; Lebar MD; Schirner K; Schaefer K; Tsukamoto H; Kahne D; Walker S J Am Chem Soc; 2014 Oct; 136(42):14678-81. PubMed ID: 25291014 [TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics. Leimkuhler C; Chen L; Barrett D; Panzone G; Sun B; Falcone B; Oberthür M; Donadio S; Walker S; Kahne D J Am Chem Soc; 2005 Mar; 127(10):3250-1. PubMed ID: 15755121 [TBL] [Abstract][Full Text] [Related]
19. LiaRS reporter assay: A simple tool to identify lipid II binding moieties in lantibiotic nukacin ISK-1. Elsayed KM; Islam MR; Abdullah-Al-Mahin ; Nagao JI; Zendo T; Sonomoto K J Biosci Bioeng; 2017 Mar; 123(3):398-401. PubMed ID: 27856233 [TBL] [Abstract][Full Text] [Related]
20. Targeting a cell wall biosynthesis hot spot. Müller A; Klöckner A; Schneider T Nat Prod Rep; 2017 Jul; 34(7):909-932. PubMed ID: 28675405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]